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I. Introduction
Colorectal cancer(CRC) is the third and second most common cancer in
men and women, respectively, worldwide (Ferlay, et al., 2010). In Korea,
it is the third most common cancer overall, and the second most
common cancer in men [2]. A Westernized life style and diet is thought
to be one of the major reasons for the observed increase in incidence of
CRC in Korea and in other developed countries (National Cancer Center,
2014, National Cancer Center, Shin, et al., 2012). Numerous studies have
shown that colorectal carcinogenesis is associated with metabolic
disorders, such as obesity, metabolic syndrome, and diabetes mellitus;
however, the exact mechanisms are currently unclear (Jee, et al., 2008,
Ishim, et al., 2013, Giovannucci, et al., 2010).
The incidence of diabetes mellitus has been increasing vastly in most
countries, including Korea (Shaw, et al., 2010, Kim, 2011) and it
undoubtedly represents one of the most challenging health issues of the
21st century (International Diabetes Federation, 2014). Many studies have
reported that diabetes mellitus is related with the increasing incidence of
CRC (Giovannucci, et al., 2010, Larsson et al., 2005, Deng et al., 2012, De
Bruijn, et al., 2013, Yuhara et al., 2011, Zanders et al., 2014, Inoue et al.,
2012). Recently, diabetes mellitus as well as impaired fasting glucose(IFG)
as a marker of pre-diabetes, have been spotlighted as a way to minimize
the medical and socio-economic burden of diabetes mellitus, by
- 2 -
permitting early detection and intervention. Several studies have reported
that pre-diabetes is a possible risk factor of cardiovascular diseases
(Barzilay et al., 1999, Kim et al., 2013); however, there is currently no
consensus about the association of cancer incidence and IFG. As CRC is
broadly known to be a metabolic-related cancer, studying the incidence
of CRC and its correlation with fasting serum glucose(FSG) levels could
be helpful to design better prevention strategies for controlling the
progression and development of CRC.
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Ⅱ. Material and Methods
This study was approved by the institutional review board of the
Yonsei University, and all study participants provided written consent,
according to the principles of the Declaration of Helsinki.
1. Study population
This is the Korean Metabolic Syndrome Research Initiative study in
Seoul, initiated in 2005. The initial study population included 183,336
individuals who visited health promotion centers in university hospitals
between 2004 and 2011. Among the total sample population, 278
participants who were diagnosed with colorectal cancer as well as 7132
patients with diabetes mellitus at the time of enrollment were excluded
from the study. In addition, 249 subjects with an extremely low body
mass index(BMI)<16 kg/m2, weight≤30 kg, or height≤130 cm were
excluded. Therefore, the final subject group consisted of 175,677 Korean
men and women(men, n = 103,452; women, n = 72,225). The mean
follow-up period was 4.7 years. A detailed description of the Korean
Cancer Prevention Study-II design and methods of selection of
participants has been published previously (Jee et al., 2010).
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2. Questionnaire and anthropometric measurements
Each participant was interviewed by using a structured questionnaire
to collect the following details: education level(<high school vs.≥high
school), smoking history(never smoked, ex-smoker, or current smoker),
alcohol drinking(non-drinker vs. consumer of any amount of alcohol on a
regular basis), and regular exercise(yes or no). Participant height and
weight were measured while the participants were wearing light clothing.
BMI was calculated by dividing the weight(kg) by the square height(m2).
Systolic and diastolic blood pressures were measured after a rest period
of at least 15 min.
3. Blood collection and biochemical analyses
For clinical chemistry assays, serum—separated from peripheral venous
blood—was obtained from each participant after a minimum fasting
period of 12h, and stored at −70°C until the time of analysis. Levels of
FSG, total cholesterol, triglyceride, low-density lipoprotein cholesterol, and
high-density lipoprotein cholesterol were measured by using a COBAS
INTEGRA 800 and a Hitachi-7600 analyzer(Hitachi, Tokyo, Japan).
4. Diagnosis of CRC
Data regarding the incidence of CRC was obtained from the records of
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the National Cancer Registry and from the hospitals where the
participants had been treated. Although Korea has a National Cancer
Registry, reports were not complete during the time of follow-up;
therefore, hospital admission files were used to identify the first
admission events for CRC. An incident of CRC was considered to have
occurred on the basis of a positive report either from the National
Cancer Registry or upon hospital admission for a cancer diagnosis.
According to the International Classification of Diseases, Tenth
Revision(ICD-10), CRC was coded as C18-C20 (World Health
Organization, 2011).
5. Statistical analysis
Person-years were calculated from the baseline enrollment to 2011, the
date of CRC diagnosis, death, or loss of follow-up. Crude incidence
rates(per 100,000 person-years) were calculated with the person-years and
number of cases of CRC. Hazard ratios(HRs) were calculated by using
the Cox proportional hazard model, after adjusting for age, sex, BMI,
smoking status, alcohol consumption, and regular exercise. BMI as an
indicator of obesity was adjusted in this study for the effect to be
minimized. The analyses were performed separately for men and women.
Subsequently, the same analyses were used after the FSG levels were
divided into high(FSG≥100 mg/dL) or low(FSG<100 mg/dL), and into 4
categories on the basis of the cut-offs of 100 mg/dL, 110 mg/dL, and
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126mg/dL, in the total population, and in men and women separately.
Kaplan-Meier survival analyses were used to evaluate the incidence
probability of CRC in the four FSG groups. All statistical tests were
two-sided, and statistical significance was determined as P < 0.05. SAS
statistical software, version 9.2(SAS Institute Inc., Cary, NC) was used for
all analyses.
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Ⅲ. Results
The basic characteristics of the participants(103,452 men and 72,225
women) are summarized in Table 1. A total of 320 patients were newly
diagnosed with CRC among the 175,677 participants over 816,143 total
person-years(mean follow-up, 4.7 years). The crude incidence rates per
100,000 person-years were 39.21 overall, 47.73 for men, and 27.31 for
women. The incident rate increased with age in both men and
women(Table 2). The HR for developing CRC in subjects with high FSG
was statistically significant(HR, 1.40; 95% confidence interval [CI], 1.10–
1.78), and the association remained significant after adjusting for
confounding variables(HR, 1.45; 95% CI, 1.10–1.90). When the same
analysis was performed according to the sex of the subjects, the HR for
developing CRC was relatively high in men(HR, 1.51; 95% CI, 1.11–
2.05), whereas no association was observed in women (HR, 1.23; 95% CI,
0.67-2.26)(Table 3). When Cox proportional hazards regression models
were applied to site-specific CRC, only the HR of rectal cancer was
statistically significant in both the total population and men(HR, 1.49;
95% CI, 1.00–2.24; HR, 1.59; 95% CI, 1.01–2.48, respectively), whereas
no significant associations were observed for proximal and distal colon
cancers in all groups(Table 4). Increasing trends in the HR of CRC
according to the increase of FSG levels were observed(P=0.006 in the
total population[Supplementary Fig. 1], P=0.005 in men[Fig. 1], and P=
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0.67 in women[data not shown]). When the obese and non-obese groups
were sub-analyzed, interestingly, the incidence of distal colon cancer in
men was found to be significantly associated with high serum glucose
levels in the non-obese group(BMI<25), whereas the incidence of distal
colon cancer in women was found to be significantly associated with
high serum glucose levels in the obese group(BMI≥25). However, due to
the low incidences of distal colorectal cancer in women during a
relatively short follow-up period, the confidence interval was observed to
be wide. [Supplementary Table 1].
Figure 2 illustrates the incidence trends of CRC during the follow-up
period, as determined using the Kaplan-Meier method in the four FSG
groups. The cumulative CRC incidence probabilities gradually increased
over time, with a sharper increase observed in the high-level FSG
groups compared to the low-level FSG groups.
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Ⅳ. Discussion
In this prospective cohort study of a large Korean population, we
found that the incidence of CRC was positively associated with FSG
levels. Especially, hyperglycemia including IFG correlated with CRC
incidence in men, indicating that pre-diabetes status might be related
with colorectal carcinogenesis. This finding was consistent with several
previous studies, although the specific classification and study designs
differed between the studies. In the Framingham Heart Study-offspring
cohort, the incidence of CRC was found to higher in subjects with IFG.
The early exposure of high glucose levels displayed a strong association
with CRC, and the HRs proportionally increased with the exposure
period of IFG(IFG exposure 5–10 y: HR, 1.76; 95% CI, 1.09–2.84; 10–
20y: HR, 2.55; 95% CI, 1.60–4.05;and ≥20y: HR, 3.26; 95% CI, 1.73–6.14)
(Prekh et al., 2013). Another study in Korea, similar to ours, showed the
association between IFG and incidence of CRC in men only(glucose, 90–
109mg/dL: HR, 1.08; 95% CI, 1.01–1.15; glucose, 110–125mg/dL: HR,
1.14; 95% CI, 1.02–1.27), however, unlike in our study, the incidences of
site-specific colorectal cancer were not examined (Jee et al., 2005). These
two studies were commonly adjusted for age, sex, smoking, and alcohol
use, however diet, calori intake or family history of colorectal cancer
were not included.
On the other hand, a prospective cohort study in Austria found that
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the association between IFG and the risk of CRC was higher in
women(HR, 1.57; 95% CI, 1.08–2.28) than in men (HR, 1.37; 95% CI, 0.94
–2.01) (Rapp el al., 2006). These inconsistent results between men and
women might be explained by considering the interaction of sex
hormones, inadequate control of confounding factors, and different
sample sizes between the studies. Furthermore, a study in a Swedish
cohort revealed that the association between hyperglycemia and colon
cancer was not significant (Stattin et al., 2007).
There are many hypotheses about the mechanisms behind the potential
association between hyperglycemia and CRC. Hyperinsulinemia through
insulin-like growth factor signaling (Ish-Shalom et al., 1997, Khandwala et
al., 2000, Cohen et al., 2012), chronic inflammation (Yu et al., 2009, Danel
et al., 2013), delayed bowel transit time (Will et al., 1998), changes in
bile acid (Stadler et al., 1988), and imbalanced microbiota in the bowels
(Tlaskalová-Hogenová el at., 2011), have all been suggested. Recently, a
study of Kannisto Vetvik et al. demonstrated that involvement of
adiponectin-AMP-activated protein kinase α signaling in colorectal
carcinogenesis was depending on the glucose levels (Katja et al., 2014).
As IFG is an early stage of diabetes mellitus, similar mechanisms are
likely responsible for the association between IFG and CRC as well. In
addition, the common risk factors of diabetes mellitus and CRC, such as
central obesity, high BMI, physical inactivity, and a high-calorie diet,
have also been suggested to be the cause of the observed association.
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However, the association persisted after controlling for these risk factors
in our study, suggesting that this is not the only explanation.
In the present study, the incidence of rectal cancer was associated with
elevated glucose levels in men but not in women. There have been
several studies about the site-specific relative risks of CRC according to
glucose levels, but the results are inconsistent with those of the present
study. The Iowa Women’s Health study reported that the incidence of
proximal colon cancer was associated with diabetes mellitus (Limburg et
al., 2005), whereas the study by He et al. and the Nurses’ Health study
found that the incidence of right and left colon cancer, but not rectal
cancer, were significantly associated with diabetes mellitus (He et al.,
2010, Hu et al., 1999). Moreover, a prospective study in Sweden
demonstrated a slightly higher risk of cecum/ascending colon cancer
compared to other sites of CRC in patients with diabetes mellitus
(Weiderpass et al., 1997). Rectal cancer is known to be the most common
subsite of colorectal cancer in Asian male (Shin et al., 2012), whereas
proximal colon cancer is known to be the most common site of
colorectal cancer for Asian womens,Whites and Blacks living in U.S.
(Murphy et al., 2011, Wu et al., 2004). This might be the one of the
contributing factors of the association. However, the mechanisms behind
the site-specific incidence of CRC, and its association with hyperglycemia,
have not yet been fully explained.
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When the glucose levels were sub-classified into 4 categories in our
study, the HR of each group displayed an increase in trend in the
incidence of CRC; however, the HRs were not statistically significant in
the group with fasting glucose levels of 110 to 126mg/dL. This might be
owing to the sample size of patients with CRC and the study duration
not being sufficient, leading to poor statistical power.
There are several limitations to our study. First, the participants in the
cohort were followed-up for a relatively short period, and therefore it
may not have been enough time to fully detect the cancer incidence.
Second, no information about insulin levels, cancer stages, and
comorbidities were available for this study, and may have been
confounding factors, making the association between CRC and FSG levels
more complicated to establish. Third, this cohort consisted of people who
visited health screening centers at university hospitals, and, therefore,
selection bias existed. Moreover, variability in the laboratory methods
used at each center might have influenced the results. Lastly, the cases
of colorectal cancer occurred during the first year, included in the
analysis, may have little effect from glucose level during carcinogenesis.
However, when those cases were excluded in the analysis, the association
between elevated glucose level and rectal cancer incidence was observed
to be attenuated. Despite the limitations, a major strength of this study
is that it represents the largest cohort study performed to date, with 19
multi-centers in Korea tracking the nationwide incidence of cancer.
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V. Conclusions
Our findings suggest that pre-diabetes and diabetes statuses are related
with CRC development and progression in men. Based on these results,
early detection and intervention aimed at controlling fasting serum
glucose level may represent a novel way of preventing colorectal
carcinogenesis. Further experimental studies and larger, longer prospective
epidemiologic studies are needed to fully understand the biological and
molecular mechanisms of hyperglycemia and its association with
carcinogenesis and the incidence of site-specific CRC.
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Figure 1. Hazard ratio and 95% confidence interval for colorectal cancer
according to fasting serum glucose levels in men.
Abbreviations: HR, Hazard Ratio; FSG, fasting serum glucose
*HR from Cox proportional hazards regression analysis adjusted for age, sex,
body mas index, smoking, alcohol drinking, and regular exercise. (P trend =0.03)
†P value<0.05
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Figure 2. Culmulative colorectal cancer incidence probability according
to fasting serum glucose levels.
Abbreviations: CRC, colorectal cancer; FSG, fasting serum glucose
*Cumulative CRC Incidence Probability, using Kaplan-Meier survival analysis.
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Supplementary Figure 1. Hazard ratio and 95% confidence interval for
colorectal cancer according to fasting serum glucose levels in men and
women.
Abbreviations: HR, Hazard Ratio; FSG, fasting serum glucose
HR* from Cox proportional hazards regression analysis adjusted for age, sex,
body mass index, smoking, alcohol drinking, and regular exercise. (P trend
=0.04)
†P value<0.05
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Total (n=175,677) Men (n=103,452) Women (n=72,225)
Variables Mean ± SD Mean ± SD
Age (years) 42.0 ± 9.8 41.5 ± 11.2
BMI (kg/m2) 24.4 ± 2.9 22.3 ± 3.1
Systolic BP (mmHg) 121.4 ± 13.5 112.9 ± 15.1
Diastolic BP (mmHg) 76.6 ± 10.0 70.6 ± 10.1
FSG (mg/dL) 94.0 ± 16.7 87.9 ± 13.3
Total cholesterol (mmol/L) 192.7 ± 33.4 184.6 ± 33.3
Triglyceride (mmol/L) 158.0 ± 100.7 100.5 ± 60.4
HDL-cholesterol (mmol/L) 49.1 ± 9.7 57.7 ± 11.4
LDL-cholesterol (mmol/L) 115.8 ± 62.2 108.0 ± 30.8
Table 1. Basic characteristics of study participants.
Abbreviations: BMI, body mass index, BP, blood pressure; FSG, fasting serum
glucose; HDL, high-density lipoprotein; LDL, low-density lipoprotein
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Men (n=103,452) Women (n=72,225)
Person-year CRC IRa Person-year CRC IR
a
Overall 816142.7 320 39.21
Sex 475625.3 227 47.73 340497.9 93 27.31
Duration of
f/u (years)
<1 87.8 23 26195.9 77.2 16 20725.4
1–2 841.4 27 3208.9 701.0 9 1283.9
2–3 1804.0 20 1108.6 1179.9 12 1017.0
3–4 127695.0 45 35.2 90426.5 19 21.0
4≤ 345209.6 112 32.4 248120.3 37 14.9
Location
of CRC
Proximal 95.7 35 36572.6 61.9 24 38772.2
Distal 162.8 66 40540.5 45.8 25 54585.2
Rectal 287.1 113 39359.1 104.4 40 38314.2
Table 2. Person year, incident case, and crude incidence rate of colorectal
cancer in men and women
Abbreviations: CRC, colorectal cancer; IR, incidence rate; PY, Person-year
a Incidence rate per 100,000 person-year
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Person-year CRC IRa HRb 95% CI HRc 95% CI HR d 95% CI
Fasting serum glucosee (Total)
Low 677675.6 221 32.61 1.00 1.00 1.00
High 138467.0 99 71.50 1.40 1.10-1.78 1.45 1.11-1.90 1.45 1.10-1.90
Fasting serum glucosee (Men)
Low 375362.6 145 38.63 1.00 1.00 1.00
High 100275.2 82 81.77 1.54 1.17-2.02 1.51 1.12-2.05 1.51 1.11-2.05
Fasting serum glucosee (Women)
Low 302313.0 76 25.14 1.00 1.00 1.00
High 38191.9 17 44.51 0.99 0.57-1.70 1.25 0.68-2.28 1.23 0.67-2.26
Table 3. Incidence rate and hazard ratio for developing colorectal
cancer in individuals with high or low fasting serum glucose
levels
Abbreviations: CRC, colorectal cancer; IR, incidence rate, HR, hazard ratio; CI,
confidence interval
a Incidence rate per 100,000 person-year
b Cox proportional hazards regression analysis adjusted for age and sex.
c Cox proportional hazards regression analysis adjusted for age, sex, and body
mass index.
d Cox proportional hazards regression analysis adjusted for age, sex, body mass
index, smoking, alcohol drinking, and regular exercise.
e Low <100 mg/dL, high≥100 mg/dL
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Table 4. Incidence rate and hazard ratio for developing proximal colon,
distal colon, and rectal cancers in individuals with high or
low fasting serum glucose levels
Proximal Colon Cancer Distal Colon Cancer Rectal Cancer
HRa 95% CI HRa 95% CI HRa 95% CI
Fasting serum glucoseb (Total)
Low 1.00 1.00 1.00
High 1.42 0.77-2.62 1.60 0.99-2.61 1.49 1.00-2.24
Fasting serum glucoseb (Men)
Low 1.00 1.00 1.00
High 1.69 0.81-3.53 1.53 0.88-2.64 1.59 1.01-2.48
Fasting serum glucoseb (Women)
Low 1.00 1.00 1.00
High 1.11 1.06-1.15 1.94 0.66-5.66 1.12 0.41-3.06
Abbreviations: HR, hazard ratio; CI, confidence interval
a Cox proportional hazards regression analysis adjusted for age, sex, body
mass index, smoking, alcohol drinking, and regular exercise.
b Low <100 mg/dL, high ≥100 mg/dL
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Proximal Colon Cancer
HRa 95% CI
Distal Colon
Cancer Rectal Cancer
HRa 95% CI HRa 95% CI
BMI<25 Fasting blood sugarb (Total)
Low 1.00 1.00 1.00
High 1.74 0.79-3.84 1.69 0.95-3.02 2.04 1.21-3.46
Fasting blood sugarb (Men)
Low 1.00 1.00 1.00
High 2.10 0.81-5.42 1.98 1.06-3.71 2.31 1.30-4.10
Fasting blood sugarb (Women)
Low 1.00 1.00 1.00
High 1.03 0.22-4.84 0.56 0.07-4.41 1.08 0.24-4.83
BMI≥25 Fasting blood sugarb (Total)
Low 1.00 1.00 1.00
High 1.18 0.46-2.99 1.54 0.64-3.70 1.00 0.54-1.84
Fasting blood sugarb (Men)
Low 1.00 1.00 1.00
High 1.31 0.42-4.08 0.89 0.31-2.59 1.00 0.50-2.00
Fasting blood sugarb (Women)
Low 1.00 1.00 1.00
High 0.93 0.18-4.86 11.05 1.21-101.15 0.98 0.26-3.70
Supplementary Table 1. Incidence rate and hazard ratio for developing
proximal colon, distal colon, and rectal cancers in individuals with
high or low fasting serum glucose levels
Abbreviations: BMI, body mass index; HR, hazard ratio; CI, confidence interval
a Cox proportional hazards regression analysis adjusted for age, sex, body mass
index, smoking, alcohol drinking, and regular exercise.
b Low <100 mg/dL, high ≥100 mg/dL
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Abstract
Association between fasting serum glucose levels and
incidence of colorectal cancer
: The Korean Cancer Prevention Study-II
Hyun-Young Shin
Department of Epidemiology
Then Graduate School of Public Health, Yonsei University
Directed by Professor Sun Ha Jee
The incidence of colorectal cancer(CRC) is steadily increasing
worldwide. Numerous studies have demonstrated that diabetes mellitus is
related to an increased risk of CRC; however, the association between
impaired fasting glucose and CRC is unclear. Therefore, we evaluated the
correlation between the incidence of fasting serum glucose(FSG) levels
and CRC, which can be used to develop novel methods for preventing
CRC.
A total of 183,336 individuals from the Korean Metabolic Syndrome
Research Initiative study were enrolled between 2004 and 2011. The
incidence of CRC was assessed during a mean follow-up of 4.7 years.
Hazard ratios(HR) for CRC according to FSG levels were calculated with
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the Cox proportional hazard model adjusted for age, sex, body mass
index, smoking status, alcohol consumption, and regular exercise.
The risk of developing CRC in subjects with high FSG was
significant(HR, 1.45; 95% confidence interval [CI], 1.10–1.90) in total
population, and the risk was higher in men(HR, 1.51; 95% CI, 1.11–
2.05). The HR of rectal cancer was significantly higher in men in the
high FSG group and the HR of proximal cancer was significantly higher
in women in the high FSG group.
The incidence of CRC positively correlated with FSG levels in men.
Therefore, early detection and intervention for controlling elevated
glucose levels may be indicated as a way to prevent carcinogenesis.
Further studies are needed to elucidate the biological and molecular
mechanisms of hyperglycemia and its relationship with carcinogenesis
and the site-specific incidence of CRC.
Key Words: colorectal cancer, fasting serum glucose, hyperglycemia,
impaired fasting glucose, incidence, rectal cancer
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Abstract (in Korean)
한국인에서의 공복혈당과 대장암 발생의 관련성 연구 
: The Korean Cancer Prevention Study-II
<지도교수 지선하>
연세대학교 보건대학원 역학과
신현영
연구배경 : 전세계적으로 대장암 발병이 증가하고 있는 가운데, 수많은 연
구를 통해 당뇨와 대장암의 연관성에대해 보고되어 왔다. 하지만 공복혈당
과 대장암과의 관련성은 아직 명확하지 않은 상태이다. 본연구의 목적은 공
복혈당과 대장암의 관련성을 확인하여, 대장암 예방에 기여할수 있을 위험
인자를 확인하고자 한다.
방법 : 2004년부터 2011까지의 Korean Metabolic Syndrome Research
Initiative study에서 183,336명의 참가자를 모집하고, 평균 4.7년동안의 추적
관찰을 통하여 대장암의 발병사례를 수집한다. 나이, 성별, 비만도, 흡연여
부, 음주여부 및 운동상태를 보정한 Cox proportional hazard model 을 통
하여 대장암 발병의 Hazard ratios를 구한다.
결과 : 한국남성에서 대장암 발병과 공복혈당과의 양의 상관관계를 확인
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하였다. 특히, 대장암 발병 위치에 따른 분석에서, 남성은 직장암에서, 여성
은 근위부 대장암에서 높은 공복혈당과 관련성이 있음을 확인하였다. 그러
므로 공복혈당을 조기에 발견하고 이를 낮추기 위한 노력이 대장암 형성과
정을 예방할 수 있을 것으로 기대한다. 앞으로 높은 공복혈당과 암형성과정
의 분자생물학적인 메커니즘과 대장암 발생위치와의 관련성을 밝혀내기 위
한 추가적인 연구가 필요할 것으로 사료된다.
핵심되는 말 : 대장암, 공복혈당, 고혈당, 내당능장애, 발병, 직장암 
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